https://www.selleckchem.com/pr....oducts/tuvusertib.ht
3% and 76.4%, respectively. Tumor growth-free survival of patients with SV 2.06 cm/second and patients with SV ≤2.06 cm/second at 2 years was 30.8% and 68.9%, respectively. The Cox hazard model demonstrated a significant risk for future tumor growth with SV 2.06 cm/second (relative risk, 2.475; 95% confidence interval, 1.11-5.37, P= 0.027). We demonstrated a positive correlation between SV with eyes open and future tumor growth. Posturographic data are objective and quantitative; thus, SV may be a potential predictor of futur
Like
Comment
Share
